drug · small molecule

AV-101

Phase 2updated 3mo ago

by $VTGN Vistagen Therapeutics, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.

indications

Major Depression

targets

Glutamate [NMDA] receptor

all catalysts(0)

nothing on the calendar yet

Trials studying AV-101

phase3Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)terminatedn=186
phase3A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)terminatedn=202

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 20m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · small molecule

save

AV-101

Phase 2updated 3mo ago

by $VTGN Vistagen Therapeutics, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.

indications

Major Depression

targets

Glutamate [NMDA] receptor

all catalysts(0)

nothing on the calendar yet

Trials studying AV-101

phase3Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)terminatedn=186
phase3A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)terminatedn=202

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 20m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

AV-101

indications

targets

all catalysts(0)

Trials studying AV-101

News(0)

Report a data issue

comments(0)

AV-101

indications

targets

all catalysts(0)

Trials studying AV-101

News(0)

Report a data issue

comments(0)